Form 4: Ocular Therapeutix Executive Sells Shares
Insider Transaction (Form 4)
Pravin Dugel, See Remarks and a Director of Ocular Therapeutix, Inc, sold 21,649 shares of common stock on August 24, 2026 for $10.77 per share.
Summary
- Open-market sale: disposed of 21,649 Common Stock at $10.77 ($233,160) on August 24, 2026; holds 2,525,429 after (Direct).
- Bona fide gift: disposed of 50,092 Common Stock on August 25, 2026 (Indirect).
- Bona fide gift: acquired 50,092 Common Stock on August 25, 2026; holds 744,903 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $233,160 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Pravin Dugel — Director, Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-24 | Open-market sale | Common Stock | 21,649 | $11 | $233.2K | 2,525,429 |
| 2026-08-25 | Bona fide gift | Common Stock | 50,092 | — | — | 0 |
| 2026-08-25 | Bona fide gift | Common Stock | 50,092 | — | — | 744,903 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-24 | Open-market sale (21,649 shares) |
| 2026-08-25 | Bona fide gift (50,092 shares) |
| 2026-08-25 | Bona fide gift (50,092 shares) |
Keywords
insider transaction, Form 4, OCUL, OCULAR THERAPEUTIX, INC, bearish, Pravin Dugel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.